Genprex CEO Confer Gets Salary Hike, Title Upgrade; Former EVP Vaczy Receives $350K Severance

Genprex, Inc.

Ryan Confer confirmed as President, CEO and CFO; base salary increased to $480,000 per year; severance reference period extended from 12 to 18 months.
Separating EVP Catherine Vaczy receives $300,000 plus $50,000 severance, acceleration of 6,125 RSUs and 4,374 options.
At June 18 annual meeting, director Brent Longnecker elected; ratification of WithumSmith+Brown as auditor; advisory say-on-pay approved and frequency set to every year.
Board adopted amended Outside Director Compensation Policy adding $15,000 annual cash retainer for non-executive Chairman.

item 5.02 item 5.07 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Ryan M. Confer

President, Chief Executive Officer and Chief Financial Officer

GNPX · Genprex, Inc.

Effective: 2024-05-08
Filed: June 24, 2024, 7:59 PM ET

Mr. Confer’s title change to President, Chief Executive Officer and Chief Financial Officer was confirmed

Departed

Catherine Vaczy

Executive Vice President, General Counsel and Chief Strategy Officer

GNPX · Genprex, Inc.

Effective: 2024-02-04
Filed: June 24, 2024, 7:59 PM ET

Catherine Vaczy, the Company’s then Executive Vice President, General Counsel and Chief Strategy Officer, notified the Company of her intention to resign.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ryan M. Confer changed role as President, Chief Executive Officer and Chief Financial Officer at Genprex, Inc..

Action: confirmed
Role: President, Chief Executive Officer and Chief Financial Officer

Exact text from the filing

Mr. Confer’s title change to President, Chief Executive Officer and Chief Financial Officer was confirmed

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Catherine Vaczy resigned as Executive Vice President, General Counsel and Chief Strategy Officer at Genprex, Inc..

Action: resigned
Role: Executive Vice President, General Counsel and Chief Strategy Officer

Exact text from the filing

Catherine Vaczy, the Company’s then Executive Vice President, General Counsel and Chief Strategy Officer, notified the Company of her intention to resign.

View on SEC.gov

Genprex, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-24-021031

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.